Chembio Diagnostics, Inc. Board Member Named Winner Of Commercialization Award By Purdue University

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MEDFORD, N.Y., Nov. 21, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care ("POC") diagnostic tests for infectious diseases, announced today that Peter Kissinger, Ph.D., a member of the company's board of directors and professor of chemistry at Purdue University, has received the Outstanding Commercialization Award for Purdue University for 2013. The award is given annually to a Purdue University faculty member in recognition of outstanding contributions to, and success with, commercializing the University's research discoveries.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC